AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
16:09
Irinel Ionel Scrioșteanu announces the installation of the last element of the bridge over the Siret on the Braila-Galati Expressway, which will be opened to traffic by the end of the year.
15:59
An exceptional Van Cleef & Arpels necklace, valued at millions of euros, was stolen from the Museum of Applied Arts in Vienna.
15:55
The Swedish army will participate in the protection of Finland's territory with Gripen aircraft at least until the end of the year.
15:55
Prosecutor Radu George Bucurică has been suspended from office by the Superior Council of Magistracy.
15:33
Donald Trump's war against Iran has caused a financial crisis in the American navy.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
